American journal of therapeutics最新文献

筛选
英文 中文
Successful Treatment of Multiple Plantar Warts Using Modified Saturated Saline Immersion: A Case Report. 改良饱和盐水浸泡成功治疗多发性足底疣1例。
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 Epub Date: 2026-08-07 DOI: 10.1097/MJT.0000000000002200
Yechen Li, Jiayi Dong, Xinyi Dai, Zhiqiang Yin
{"title":"Successful Treatment of Multiple Plantar Warts Using Modified Saturated Saline Immersion: A Case Report.","authors":"Yechen Li, Jiayi Dong, Xinyi Dai, Zhiqiang Yin","doi":"10.1097/MJT.0000000000002200","DOIUrl":"10.1097/MJT.0000000000002200","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e449-e450"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148688491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thyroid Hormone-Induced Metabolic Stress Unmasking Latent Wernicke Encephalopathy. 甲状腺激素诱导的代谢应激揭示潜伏的韦尼克脑病。
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 Epub Date: 2026-08-06 DOI: 10.1097/MJT.0000000000002154
Omar Abdul-Aziz, Musa Lughmani, Ibrahim Altorok, Akram Assaly, Ragheb Assaly
{"title":"Thyroid Hormone-Induced Metabolic Stress Unmasking Latent Wernicke Encephalopathy.","authors":"Omar Abdul-Aziz, Musa Lughmani, Ibrahim Altorok, Akram Assaly, Ragheb Assaly","doi":"10.1097/MJT.0000000000002154","DOIUrl":"10.1097/MJT.0000000000002154","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e421-e422"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148676904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Envafolimab-Associated Toxic Epidermal Necrolysis. 依伐伐利单抗相关的中毒性表皮坏死松解。
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 Epub Date: 2026-02-11 DOI: 10.1097/MJT.0000000000001913
Sheng Li, Ze Peng, Yu Qiu, Yu-Ting Gan, Wei Zhou, Bing-Jun Shi
{"title":"Envafolimab-Associated Toxic Epidermal Necrolysis.","authors":"Sheng Li, Ze Peng, Yu Qiu, Yu-Ting Gan, Wei Zhou, Bing-Jun Shi","doi":"10.1097/MJT.0000000000001913","DOIUrl":"10.1097/MJT.0000000000001913","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e406-e407"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146155793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tofacitinib: A Potential Dual-Action Agent in Resolving Generalized Granuloma Annulare and Modulating HIV Reservoirs. 托法替尼:解决广泛性肉芽肿环状和调节HIV储库的潜在双作用剂。
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 Epub Date: 2025-10-31 DOI: 10.1097/MJT.0000000000001890
Yao Lei, Xiao-Qin Wang, Bing-Jun Shi
{"title":"Tofacitinib: A Potential Dual-Action Agent in Resolving Generalized Granuloma Annulare and Modulating HIV Reservoirs.","authors":"Yao Lei, Xiao-Qin Wang, Bing-Jun Shi","doi":"10.1097/MJT.0000000000001890","DOIUrl":"10.1097/MJT.0000000000001890","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e479-e480"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145627296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iohexol-Induced Toxic Epidermal Necrolysis: A Case Report and Review of the Literature. 碘己醇致中毒性表皮坏死松解1例报告及文献复习。
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 Epub Date: 2026-07-23 DOI: 10.1097/MJT.0000000000002178
Nour Elhouda Zouaoui, Fatma Zgolli, Asma Jerbi, Imen Aouinti, Israa Dahmani, Sihem El Aidli
{"title":"Iohexol-Induced Toxic Epidermal Necrolysis: A Case Report and Review of the Literature.","authors":"Nour Elhouda Zouaoui, Fatma Zgolli, Asma Jerbi, Imen Aouinti, Israa Dahmani, Sihem El Aidli","doi":"10.1097/MJT.0000000000002178","DOIUrl":"10.1097/MJT.0000000000002178","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e429-e434"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148560759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Directions After the DAPA-STEMI Trial. DAPA-STEMI试验后的研究方向。
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 Epub Date: 2026-08-19 DOI: 10.1097/MJT.0000000000002205
Nawazish Ali, Ahmed Mustafa Khawaja, Muhammad Sohaib, Mirbaz Khan, Aqib Ali, Deen Wali
{"title":"Research Directions After the DAPA-STEMI Trial.","authors":"Nawazish Ali, Ahmed Mustafa Khawaja, Muhammad Sohaib, Mirbaz Khan, Aqib Ali, Deen Wali","doi":"10.1097/MJT.0000000000002205","DOIUrl":"10.1097/MJT.0000000000002205","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e465-e466"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148787294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mapping the Global Clinical Trial Landscape of Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: Current Status and Future Perspectives. 绘制嵌合抗原受体t细胞治疗慢性淋巴细胞白血病的全球临床试验景观:现状和未来展望。
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 Epub Date: 2026-08-19 DOI: 10.1097/MJT.0000000000002204
Yun Liao, Yike Li, Lihua Feng
{"title":"Mapping the Global Clinical Trial Landscape of Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: Current Status and Future Perspectives.","authors":"Yun Liao, Yike Li, Lihua Feng","doi":"10.1097/MJT.0000000000002204","DOIUrl":"10.1097/MJT.0000000000002204","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e467-e469"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148787323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spesolimab in Pregnancy: A Breakthrough Treatment for Coexisting Generalized Pustular Psoriasis and Hallopeau Acrodermatitis Continua. 妊娠期Spesolimab:治疗广泛性脓疱性银屑病和持续性大疱性肢端皮炎的突破性疗法。
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 DOI: 10.1097/MJT.0000000000002020
Shi Yan, Ya Deng, Juan Gong
{"title":"Spesolimab in Pregnancy: A Breakthrough Treatment for Coexisting Generalized Pustular Psoriasis and Hallopeau Acrodermatitis Continua.","authors":"Shi Yan, Ya Deng, Juan Gong","doi":"10.1097/MJT.0000000000002020","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002020","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"33 5","pages":"e443-e446"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148910615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uncomplicated Cure: The New Era of Gonorrhea Therapy With Oral Zoliflodacin. 简单治疗:口服唑氟达星治疗淋病的新时代。
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 Epub Date: 2026-07-07 DOI: 10.1097/MJT.0000000000002172
Nino Marzella, Nardine K Salgado, Hubert C Chua, Lorena Dima, Timothy Nguyen
{"title":"Uncomplicated Cure: The New Era of Gonorrhea Therapy With Oral Zoliflodacin.","authors":"Nino Marzella, Nardine K Salgado, Hubert C Chua, Lorena Dima, Timothy Nguyen","doi":"10.1097/MJT.0000000000002172","DOIUrl":"10.1097/MJT.0000000000002172","url":null,"abstract":"<p><strong>Background: </strong>Gonorrhea is a preventable and treatable infection caused by Neisseria gonorrhoeae , remaining a major public health concern because of antibiotic-resistant strains. A milestone was reached with zoliflodacin, the first therapeutic in its class in nearly 2 decades.</p><p><strong>Mechanism of action, pharmacodynamics and pharmacokinetics: </strong>Zoliflodacin is a first-in-class spiropyrimidinetrione antibacterial agent that targets type II topoisomerases DNA gyrase and topoisomerase IV enzymes essential for DNA synthesis. Its primary target is the GyrB subunit of DNA gyrase, rather than the GyrA or ParC subunits affected by fluoroquinolones. The area under the concentration-time curve/minimum inhibitory concentration is the primary pharmacokinetics and pharmacodynamics index associated with bacterial killing. Zoliflodacin binds approximately 83% to plasma proteins, undergoes extensive metabolism through cytochrome P450-mediated and non-P450-mediated pathways, has a low urinary excretion with a major fecal route elimination pathway, and an elimination half-life of around 5-6 hours.</p><p><strong>Clinical trials: </strong>Zoliflodacin demonstrated positive results for the treatment of uncomplicated urogenital gonorrhea in phase 2 and subsequently phase 3 trials. In a phase 2, multicenter, open-label RCT, the efficacy and safety of zoliflodacin was compared with ceftriaxone. Cure rates for urogenital infections were 96% (55/57) (2 g), 96% (54/56) (3 g), and 100% (28/28) (ceftriaxone). In a phase 3, multinational, open-label, noninferiority RCT, participants were randomly assigned (2:1) to receive a single 3 g oral dose of zoliflodacin or a single dose of 500 mg intramuscular injection of ceftriaxone plus 1 g oral azithromycin. The primary end point for microbiological cure was achieved in 90.9% (460/506) of patients on zoliflodacin compared with 96.2% (229/238) of the comparator, demonstrating noninferiority and good tolerability.</p><p><strong>Therapeutic advance: </strong>Oral zoliflodacin represents a novel option for the treatment of uncomplicated urogenital gonorrhea, including antibiotic-resistant strains, providing an important alternative therapy.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e395-e404"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148468463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SGLT2i Use Reduces the Risk of COPD Exacerbations Compared With DPP4is in Patients With Diabetes and Concomitant COPD: A Systematic Review and Meta-Analysis. 与DPP4is相比,糖尿病合并COPD患者使用SGLT2i可降低COPD恶化风险:一项系统回顾和荟萃分析
IF 3.5 4区 医学
American journal of therapeutics Pub Date : 2026-09-01 Epub Date: 2026-08-06 DOI: 10.1097/MJT.0000000000002193
Dua Ali, Zainab Binte Ahmad, Muhammad Waqas, Sneha Vijay, Izma Kamran Ali, Muhammad Saad
{"title":"SGLT2i Use Reduces the Risk of COPD Exacerbations Compared With DPP4is in Patients With Diabetes and Concomitant COPD: A Systematic Review and Meta-Analysis.","authors":"Dua Ali, Zainab Binte Ahmad, Muhammad Waqas, Sneha Vijay, Izma Kamran Ali, Muhammad Saad","doi":"10.1097/MJT.0000000000002193","DOIUrl":"10.1097/MJT.0000000000002193","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e435-e438"},"PeriodicalIF":3.5,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148676865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书